跳至主要内容
临床试验/NCT00612404
NCT00612404已完成不适用

Symptoms and Endoscopic Results in Consideration of Pretreatment

AstraZeneca0 个研究点目标入组 16,255 人开始时间: 2005年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
16,255
主要终点
to gain insight into the relationship between subjective gastrointestinal symptoms and findings of a laryngopharyngeal-esophagogastric endoscopy with respect to the medicinal pre-therapy;

研究概览

简要总结

Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. gastroenterologists) are asked to document relevant data in patients with gastrointestinal disorders.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with gastrointestinal disorders who need an endoscopy.

排除标准

  • limitiations; possible risks; warnings; contraindications mentioned in the SPC.

结局指标

主要结局

to gain insight into the relationship between subjective gastrointestinal symptoms and findings of a laryngopharyngeal-esophagogastric endoscopy with respect to the medicinal pre-therapy;

次要结局

  • to gain insight into the currently used treatment strategies with esomeprazole depending on endoscopic findings.

研究者

发起方
AstraZeneca
申办方类型
Industry

相似试验